Saralasin

From Wikipedia, the free encyclopedia

The introduction to this article provides insufficient context for those unfamiliar with the subject matter.
Please help improve the introduction to meet Wikipedia's layout standards. You can discuss the issue on the talk page.

Saralasin is a competitive inhibitor of angiotensin II.

[edit] External links

MeSH Saralasin
PubChem
Olsson M, Annerbrink K, Hedner J, Eriksson E (2004). "Intracerebroventricular administration of the angiotensin II receptor antagonist saralasin reduces respiratory rate and tidal volume variability in freely moving Wistar rats.". Psychoneuroendocrinology 29 (1): 107-12. PMID 14575733.
Ip S, Tsang S, Wong T, Che C, Leung P (2003). "Saralasin, a nonspecific angiotensin II receptor antagonist, attenuates oxidative stress and tissue injury in cerulein-induced acute pancreatitis.". Pancreas 26 (3): 224-9. PMID 12657946.
Tsang S, Ip S, Wong T, Che C, Leung P (2003). "Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis.". Regul Pept 111 (1-3): 47-53. PMID 12609748.